← All indications
Neoadjuvant Therapy
Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, IMMUNOTHERAPY, HYPERTHERMIA, INDUCED etc.) that is given before the main therapy.
Drugs by status
Phase 4 trials (9)
Phase 3 trials (33)
- melatonin
- anlotinib
- irinotecan
- doxorubicin
- famitinib
- fulvestrant
- fluzoparib
- gemcitabine
- paclitaxel
- lapatinib
- epirubicin
- pembrolizumab
- ribociclib
- leucovorin
- megestrol
- palbociclib
- carboplatin
- sorbitol
- cyclophosphamide
- capecitabine
- adebrelimab
- triptorelin
- docetaxel
- nedaplatin
- oxaliplatin
- cisplatin
- letrozole
- camrelizumab
- sintilimab
- toripalimab
- +3 more
Phase 2 trials (52)
- afatinib
- axitinib
- atezolizumab
- olaparib
- darolutamide
- prednisone
- entrectinib
- enzalutamide
- imatinib
- Filgrastim
- bleomycin
- apalutamide
- lenvatinib
- niraparib
- pemetrexed
- plb1001
- trastuzumab
- pyrotinib
- pertuzumab
- celecoxib
- Rezvilutamide
- belimumab
- bevacizumab
- cetuximab
- abiraterone
- pentoxifylline
- vedolizumab
- vinblastine
- vinorelbine
- Zanidatamab
- +22 more
Phase 1 trials (1)
Other trials (5)